Skip to main content
S&P 5007,722.72+0.73%DOW51,176.96+0.49%NASDAQ27,190.86+1.19%BTC$84,654.00-0.13%ETH$2,677.39-1.09%GOLD$4,172.10-0.72%OIL$91.26-1.73%
Smart Investors Daily
SID Premium
AP

NASDAQ · APYX

Apyx Medical Corporation

Healthcare · Medical - Devices

$2.55

Up+$0.05 (+2.00%)

Updated Oct 3, 2026, 11:30 PM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
134.17M
P/E ratio
-9.16
Dividend yield
0.00%
52-week range
$2.32 – $5.08
Volume
51.68K
Avg. volume
107.62K

Price performance · APYX

APYX price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 2, 2026

APYX closed at $2.55 after 20 trading sessions, down 16.39% for the selected period.

Last close
$2.55
Period change
-16.39%
Period low
$2.45
Period high
$3.06
Daily close
View OHLC price history
APYX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 2, 2026$2.51$2.60$2.50$2.5551.68K
Oct 1, 2026$2.46$2.62$2.42$2.50294.9K
Sep 30, 2026$2.58$2.8267$2.45$2.45639.62K
Sep 29, 2026$2.63$2.65$2.46$2.60338.48K
Sep 28, 2026$2.90$2.95$2.32$2.50362.38K
Sep 25, 2026$2.85$2.97$2.85$2.96131.5K
Sep 24, 2026$2.96$2.96$2.83$2.8373.75K
Sep 23, 2026$2.92$2.9616$2.89$2.9586.06K
Sep 22, 2026$2.93$2.98$2.91$2.9573.86K
Sep 21, 2026$3.06$3.075$2.86$2.91169.38K
Sep 18, 2026$3.03$3.0625$3.00$3.06152.66K
Sep 17, 2026$3.04$3.11$3.00$3.0334.19K
Sep 16, 2026$2.97$3.075$2.90$3.0180.99K
Sep 15, 2026$3.03$3.03$2.90$2.9644.08K
Sep 14, 2026$2.88$3.03$2.875$3.0289.12K
Sep 11, 2026$2.90$3.07$2.79$2.90161.33K
Sep 10, 2026$3.05$3.07$2.87$2.8990.94K
Sep 9, 2026$3.05$3.055$3.00$3.0570.42K
Sep 8, 2026$2.97$3.07$2.97$3.05128.47K
Sep 4, 2026$3.06$3.08$3.02$3.0562.06K

Latest APYX news

The latest Smart Investors Daily articles mentioning APYX.

Stock researchCompany · Overview

APYX research

Overview

Company profile and research snapshot.

Company profile

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$8.50
Implied upside
—
Analysts
—
APYX recent ratings
DateFirmRatingTarget
Sep 29, 2026Maxim GroupBuy—
Jul 13, 2026HC Wainwright & Co.Buy—
Mar 11, 2026Craig-HallumBuy—
Mar 11, 2026BTIGBuy—
Dec 16, 2025Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 29, 2026

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Patients reported high satisfaction and visible improvements in skin elasticity, youthfulness, and radianceCLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers o

Yahoo · Sep 24, 2026

Cold Plasma Market Forecasts Growth from $3.32B (2025) to $8.45B by 2032, Profiling Nordson Corporation, Apyx Medical, Plasmatreat & Enercon Industries

Cold plasma offers opportunities in healthcare, food safety, agriculture, water treatment and manufacturing through chemical-free sterilization, surface engineering and AI-enabled automation.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cold Plasma Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Cold Plasma Market research report provides strategic analysis of a market projected to grow from USD 2.39 billion in 2026 to USD 4.09 billion by 2032, at a CAG

Yahoo · Sep 15, 2026

Cold Plasma Market Forecasts Growth from $167.8M (2025) to $495.9M by 2033, Profiling Apyx Medical, Neoplas Med, Adtec Healthcare & 5 Other Key Players

Cold plasma adoption is rising in healthcare for sterilization, wound healing and cancer care, with opportunities in infection control, food safety, textiles and eco-friendly processing.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Cold Plasma Market Size, Share & Trends Analysis Report by Pressure, Application, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. Global Cold Plasma Market to Reach USD 495.9 Million by 2033 as Healthcare Applications Expand

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By